You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 299 No. 21, June 4, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Research Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Bacterial Infections
 •Drug Therapy, Other
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Incidence and Prevalence of Multidrug-Resistant Acinetobacter Using Targeted Active Surveillance Cultures

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Recent legislation mandates active surveillance cultures to detect multidrug-resistant (MDR) organisms in hospitalized patients.1 The active surveillance strategy has not been widely applied to MDR Acinetobacter, one of the most difficult gram-negative pathogens to control and treat.2 Universal active surveillance is resource-intensive and may divert resources from other infection control interventions.3 We conducted a prospective cohort study using universal active surveillance cultures to determine the prevalence and incidence of transmission of MDR Acinetobacter and to estimate the effects of targeting active surveillance to patients with recent exposure to a long-term care facility.

Methods

Universal active surveillance cultures from the axilla, wounds, sputum, and endotracheal tube aspiration were performed on admission and weekly among a cohort of 1111 adult patients admitted to medical intensive and intermediate care units of the Johns Hopkins Hospital between March and June in 2006. Isolation precautions were implemented for patients with MDR Acinetobacter . . . [Full Text of this Article]

Lisa L. Maragakis, MD, MPH
Lmaraga1@jhmi.edu

Margaret G. Tucker, BS; Redonda G. Miller, MD, MBA; Karen C. Carroll, MD; Trish M. Perl, MD, MSc
Johns Hopkins School of Medicine
Baltimore, Maryland



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.